BIO Financial Facts

Net income per share diluted attributable to Bio-Rad: 0.61
Net income per share basic attributable to Bio-Rad: 0.61
See Full Income Statement

Total liabilities and stockholders' equity: 3.87B
Property, plant and equipment, at cost: 1.18B
See Full Balance Sheet

Bio-Rad Laboratories, Inc. (BIO) Earnings

  |   Expand Research on BIO
Next EPS Date 11/3/16 *Est. EPS Growth Rate -37.1% *Last Qtr.
Average EPS % Beat Rate -8.6% Revenue Growth Rate +2.1% *Last Qtr.
Average % Move 1-Wk after EPS +2.5% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/3/16 Q216 $0.61$1.13 -$0.52$516.8M$497.8M N/A Details
5/5/16 Q116 $0.42$0.60 -$0.18$471.2M$463.9M N/A Details
2/25/16 Q415 $1.68$1.27 +$0.41$570.6M$570.8M N/A Details
11/3/15 Q315 $0.59$0.54 +$0.05$470M$495.55M N/A Details
8/6/15 Q215 $0.97$0.78 +$0.19$506.1M$494.85M N/A Details
5/5/15 Q115 $0.61$0.33 +$0.28$472.8M$474.6M N/A Details
2/26/15 Q414 $1.34$1.18 +$0.16$598.2M$593.41M N/A Details
11/4/14 Q314 $0.40$0.86 -$0.46$530.6M$525.4M N/A Details